Skip to main content
Year archive

ALK-Abelló — 2023 filings

All 41 regulatory filings released by ALK-Abelló (ALK) in 2023, sourced directly from the official regulator.

41 Filings
2023 Period
2023 filings (41)
Filing Released Lang
Regulatory Filings 2023
Regulatory Filings
2023-12-12 English
Regulatory Filings 2023
Regulatory Filings
2023-12-12 Danish
ALK expands partnership with Torii in Japan
Regulatory Filings
2023-12-12 Danish
ALK expands partnership with Torii in Japan
Regulatory Filings
2023-12-12 English
Regulatory Filings 2023
Regulatory Filings
2023-10-11 Danish
Regulatory Filings 2023
Regulatory Filings
2023-10-11 English
Large Phase 3 clinical trial successfully meets primary endpoint, confirming the potential of ALK’s tree tablet in children
Regulatory Filings
2023-10-11 Danish
Large Phase 3 clinical trial successfully meets primary endpoint, confirming the potential of ALK’s tree tablet in children
Regulatory Filings
2023-10-11 English
Earnings Release 2023
Earnings Release H1 2023
2023-08-24 English
Interim / Quarterly Report 2023
Interim / Quarterly Report H1 2023
2023-08-24 English
Six-month interim report (Q2) 2023
Interim / Quarterly Report H1 2023
2023-08-24 English
Board/Management Information 2023
Board/Management Information
2023-06-19 English
Board/Management Information 2023
Board/Management Information
2023-06-19 Danish
President & CEO Carsten Hellmann to step down end 2023. Peter Halling appointed as his successor
Board/Management Information
2023-06-19 Danish
President & CEO Carsten Hellmann to step down end 2023. Peter Halling appointed as his successor
Board/Management Information
2023-06-19 English
Regulatory Filings 2023
Regulatory Filings
2023-06-08 English
Earnings Release 2023
Earnings Release Q2 2023
2023-06-08 Danish
Large Phase 3 clinical trial successfully meets primary endpoint, confirming the potential of ALK’s house dust mite tablet in young children
Regulatory Filings
2023-06-08 Danish
Large Phase 3 clinical trial successfully meets primary endpoint, confirming the potential of ALK’s house dust mite tablet in young children
Regulatory Filings
2023-06-08 English
Earnings Release 2023
Earnings Release Q1 2023
2023-04-17 Danish
Earnings Release 2023
Earnings Release Q1 2023
2023-04-17 English
ALK announces preliminary Q1 figures and confirms its full-year revenue and earnings outlook
Earnings Release Q1 2023
2023-04-17 Danish
ALK announces preliminary Q1 figures and confirms its full-year revenue and earnings outlook
Earnings Release Q1 2023
2023-04-17 English
Director's Dealing 2023
Director's Dealing
2023-03-02 Danish
Remuneration Information 2023
Remuneration Information
2023-03-02 English
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing
2023-03-02 Danish
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing
2023-03-02 English
Director's Dealing 2023
Director's Dealing
2023-02-08 Danish
Director's Dealing 2023
Director's Dealing
2023-02-08 English
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing
2023-02-08 Danish
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
Director's Dealing
2023-02-08 Danish
Regulatory Filings 2023
Regulatory Filings
2023-02-03 English
Regulatory Filings 2023
Regulatory Filings
2023-02-03 Danish
Regulatory filing for house dust mite allergy tablet accepted for review in China
Regulatory Filings
2023-02-03 Danish
Regulatory filing for house dust mite allergy tablet accepted for review in China
Regulatory Filings
2023-02-03 English
Annual Report (ESEF) 2022
Annual Report (ESEF) FY 2022
2023-02-03 English
Annual Report (ESEF) 2022
Annual Report (ESEF) FY 2022
2023-02-03 English
Earnings Release 2022
Earnings Release FY 2022
2023-02-03 English
Annual Report 2022
Annual Report FY 2022
2023-02-03 Danish
Annual report 2022: ALK delivers sales growth of 13% with profits up 33% in 2022
Report Publication Announcement
2023-02-03 Danish
Annual report 2022: ALK delivers sales growth of 13% with profits up 33% in 2022
Annual Report FY 2022
2023-02-03 English